Opportunistic infections and inflammatory bowel disease

doi:10.3969/j.issn.1004-583X.2016.08.014

Clinical Focus

Previous Articles Next Articles

Opportunistic infections and inflammatory bowel disease

1.Department of Gastroenterology， the Second Hospital of Hebei Medical University;
Hebei Key Laboratory of Gastroenterology; Hebei Institute of Gastroenterology， Shijiazhuang 050000， China；
2.Department of Gastroenterology，215 Hospital of Shaanxi Nuclear Industry，Xianyang 712000， China

Online:2016-08-05 Published:2016-07-30
Contact: Corresponding author: Yin Fengrong，Email: yinfr@163.com

Abstract

Abstract: Application of immunosuppression opens a door for the treatment of inflammatory bowel disease (IBD)， while the opportunistic infections (OI) have emerged in it. Opportunistic infections in patients with IBD include viral infections， bacterial infections， fungal infections and parasite infections and so on. The OI increase the mortality and morbidity of IBD patients， so early detection and identification of IBD with OI and early treatment or preventive treatment were extremely important.

Key words: inflammatory bowel diseases, infection, treatment

Lei Lei1，2， Zhang Xiaolan1， Yin Fengrong1. Opportunistic infections and inflammatory bowel disease[J]. Clinical Focus, doi: 10.3969/j.issn.1004-583X.2016.08.014.

Add to citation manager EndNote|Ris|BibTeX

URL: https://lchc.magtechjournal.com/EN/10.3969/j.issn.1004-583X.2016.08.014

https://lchc.magtechjournal.com/EN/Y2016/V31/I8/865

[1]	Wang Sheng, Ke Youtao. The impact of information-based management mode on the quality of hospital infection prevention and control of multidrug-resistant bacteria [J]. Clinical Focus, 2025, 40(4): 344-348.
[2]	Huang Xingzhou, Zheng Weihua, Zhang Shutong, Chen Yanhao. Clinical efficacy and safety of drug-eluting beads for bronchial artery chemoembolization versus conventional bronchial artery chemoembolization alone for advanced non-small cell lung cancer [J]. Clinical Focus, 2025, 40(3): 243-250.
[3]	Qian Chenying, Yan Wenjun, Huang Yan, Zhao Zhi. Analysis of risk factors for multidrug-resistant bacterial infection in patients with decompensated cirrhosis [J]. Clinical Focus, 2025, 40(2): 143-146.
[4]	Wu Wanfeng, Wang Yunyun, Yang Daokun. Comparative study on the clinical efficacy of different antiviral drugs in the treatment of COVID-19 [J]. Clinical Focus, 2025, 40(2): 147-152.
[5]	Wang Ying, Zhong Bohua, Wang Lifang, Lang Qiuyan, Luo Haibin, Wang Shulin, Li Chunpeng, Liao Min. Epidemiological characteristics of hospital-acquired infections in pediatric patients supported by extracorporeal membrane oxygenation: A meta-analysis [J]. Clinical Focus, 2025, 40(1): 14-20.
[6]	Meng Weili. Clinical management for tuberculosis patients managed by different prevention and treatment systems in the Xicheng District in Beijing [J]. Clinical Focus, 2024, 39(3): 244-248.
[7]	Feng Yu, Lang Xiaoqing, Wang Gang, Guo Shuping. A case of scrub typhus without eschar located in a rare location [J]. Clinical Focus, 2024, 39(3): 249-252.
[8]	Ren Lei, Liu Ye, Bao Shuyou, Li Kuifang. Blastic plasmacytoid dendritic cell neoplasm: Two cases and literature review [J]. Clinical Focus, 2024, 39(3): 253-258.
[9]	Liu Wanqi, Fan Shuqin, Zhuang Ruixue, He Feng, Liu Zhenchuan, Xie Zhongxiang. Intracranial infection of varicella zoster virus in adults: Clinical analysis of 5 cases [J]. Clinical Focus, 2024, 39(2): 149-154.
[10]	He Tian, Han Linqiu, Shi Zuxin, Shen Mingyan. Incidence and risk factors of postoperative multidrug-resistant bacterial infections in liver transplant patients: A meta-analysis [J]. Clinical Focus, 2024, 39(11): 965-973.
[11]	Wang Jiaqi, Meng Jianbo, Song Xiaoning, Zhang Jinqiao, Zang Meirong, Lu Jiapei, Suo Jing. Clear cell renal cell carcinoma combined with multiple myeloma: A case report and literature review [J]. Clinical Focus, 2024, 39(11): 1021-1025.
[12]	Li Zhenan, Zhu Xuejuan, Li Shang, Wang Junmin. Effect of glucocorticoids with varied courses on the prevention of esophageal stricture after esophageal submucosal dissection [J]. Clinical Focus, 2024, 39(10): 896-900.
[13]	Qin Qiaoling, Mo Ranghui, Chen Xinyi. Efficacy and safety of the direct-acting anti-HCV therapy based on efavirenz-containing regimen on HIV/HCV co-infected patients [J]. Clinical Focus, 2024, 39(10): 921-924.
[14]	Lyu Chang, Zhou Liming. Correlation between the TNF-α-308 gene polymorphism and gastric cancer susceptibility: A meta-analysis [J]. Clinical Focus, 2023, 38(9): 779-787.
[15]	Liu Yan, Liu Qiong, Liang Xiaomei, Liu Bing. Secondary infection of spontaneous perirenal hemorrhage with fever as the main symptom: A case report and literature review [J]. Clinical Focus, 2023, 38(9): 823-826.

Opportunistic infections and inflammatory bowel disease

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments